Straight TalkPharmacy Technicians:Truth and ConsequencesWith the flu season quicklyapproaching, imagine anabsolutely unbearable workdayin your pharmacy. Anticipating theworst, you call in extra pharmacists andpharmacy technicians to help fill whatare expected to be some of the busiestprescription days of the year. Sureenough, on a typical day during the fluoutbreak, a line starts early at the prescriptiondrop-off counter and continuesto build throughout the day. Carsare stacked up at the drive-through prescriptionwindow as though McDonald’swere giving out free Big Macs. As physicians’offices open, the pharmacy’sphones ring incessantly with new prescriptionorders and permissions to refillolder prescriptions. Everyone is workingto their fullest capacity, which necessitatesextra effort from all pharmacy personnel.<strong>Pharmacist</strong>s’ and technicians’fingers are furiously tapping the computerkeyboards trying to input data asquickly as possible while making sure important informationis accurately recorded into patients’ medicalrecords. Medication stock bottles are being pulledfrom every shelf in the pharmacy, with their tabletsand capsules ready to be poured out into the smallerprescription containers and bottles lined up on theprescription counter, each awaiting a label withinstructions to be affixed to it. Once filled, the prescriptionswill be checked by a pharmacist beforebeing dispensed to the patient. The pharmacy counteris a mess and resembles the trading floor of the NewYork Stock Exchange after a busy day, with notes onscrap paper strewn everywhere. Pharmacy techniciansand pharmacists line up to fill the waiting prescriptionbottles and vials like a General Motors assembly line.And then it happens. . . a pharmacy technician preparesa prescription that contains a fatal dose of themedication. Because of the craziness in the pharmacy,the error gets passed over by a pharmacist who is supposedto check each and every prescriptionbefore it is dispensed.A doomsday scenario, you say, thatwould never happen in your pharmacy?Maybe, but the truth is, it does happen,and it is more than likely that thepharmacist, not the technician, will paythe consequences of any error. Dependingon its severity, the error could resultin a hefty fine and prison time for thepharmacist. While the above scenariomay be fictitious, a case reported byU.S. <strong>Pharmacist</strong>’s legal contributor, JesseC. Vivian, BS Pharm, JD, in thismonth’s Legal Considerations column(page 66), is unfortunately all too real.In that case of a fatal error, the technicianwas charged with negligenthomicide but was given a “get out ofjail free” card by the court, wasn’t evenfined, and actually went back to workin a retail pharmacy. The pharmacist,however, was found guilty of involuntarymanslaughter and faced up to 5years in prison and a $10,000 fine. His license wasrevoked, and he will probably never work again as apharmacist. All this because he did not check theaccuracy of a prescription filled by the technician.The column should be a wake-up call for everypharmacist who works closely with one or more pharmacytechnicians. While it is true that each case ofnegligence involving a technician will be judged onthe merits of the case, the message is clear. The truthis that if a pharmacist is not diligent about checking atechnician’s work, the consequences could be dire.Harold E. Cohen, RPhEditor-in-Chiefhcohen@jobson.com4U.S. <strong>Pharmacist</strong> • November 2009 • www.uspharmacist.com
U.S. <strong>Pharmacist</strong>What’s NewsEditorial Board of AdvisorsJoseph Bova, RPhCommunity Pharmacy Owner,Cary’s Pharmacy,Dobbs Ferry, New York;Member, NYS Board of PharmacyCarmen Catizone, RPhExecutive Director, National Associationof Boards of PharmacyJohn M. Coster, PhD, RPhSenior VP of Government AffairsNational Community <strong>Pharmacist</strong>s Assoc.Hewitt (Ted) W. Matthews, PhDDean, Southern School of Pharmacy,Mercer University, AtlantaDavid G. Miller, RPhPharmacy Affairs, Merck & Co., Inc.,West Point, PennsylvaniaMario F. Sylvestri, PharmD, PhDSenior Director, Medical Science Liaisons,Amylin PharmaceuticalsRay A. Wolf, PharmDMedical Education, Sanofi AventisMary Ann E. Zagaria,PharmD, MS, CGPSenior Care Consultant andPresident, MZ Associates, Inc.,Norwich, New YorkContributing EditorsLoyd V. Allen, Jr., PhDConnie Barnes, PharmDBruce Berger, PhDR. Keith Campbell, RPh, CDEPatrick N. Catania, PhD, RPhR. Rebecca Couris, PhD, RPhEd DeSimone, PhD, RPhRonald W. Maddox, PharmDSomnath Pal, BS (Pharm), MBA, PhDW. Steven Pray, PhD, DPhM. Saljoughian, PharmD, PhDJesse C. Vivian, BS Pharm, JDSend your comments viaEDITOR@USPHARMACIST.COMMail: 160 Chubb Avenue, Suite 306Lyndhurst, NJ 07071Telephone: (201) 623-0999Editorial Dept. Fax: (201) 623-0991Internet: www.uspharmacist.comFDA Approves Gardasil for Genital Warts in Men and BoysSilver Spring, MD — The FDA approved the vaccine Gardasil for theprevention of genital warts resulting from the human papillomavirus (HPV)types 6 and 11 in boys and men age 9 through 26 years. A randomized trial of4,055 males age 16 through 26 showed that Gardasil was 90% effective inpreventing genital warts, and studies measuring the immune response of malesage 9 through 15 were equally positive. Each year, about two out of every1,000 men in the United States are diagnosed with genital warts. Gardasilcurrently is approved for use in girls and women age 9 through 26 for theprevention of cervical, vulvar, and vaginal cancer caused by HPV types 16 and18; precancerous lesions caused by types 6, 11, 16, and 18; and genital wartscaused by types 6 and 11. Most genital warts are caused by HPV infection,which is the most common sexually transmitted infection in the U.S.IMS Predicts 4% to 6% Global Pharma Market Growth Next YearNorwalk, CT — IMS Health reported that the value of the globalpharmaceutical market in 2010 is expected to grow 4% to 6% on aconstant-dollar basis, exceeding $825 billion. The forecast predicts globalpharmaceutical market sales to grow at a 4% to 7% compound annual ratethrough 2013, and considers the impact of the global macroeconomy, thechanging mix of innovative and mature products, and the rising influence ofhealth care access and funding on market demand. The value of the globalpharmaceutical market is expected to expand to $975+ billion by 2013.“Overall, market growth is expected to remain at historically low levels, butstronger-than-expected demand in the U.S. is lifting both our short- andlong-term forecasts,” said Murray Aitken, senior vice president, HealthcareInsight, IMS Health.FDA Warns About Illegal H1N1 Vaccines on the WebSilver Spring, MD — The FDA warned consumers about purchasing anyproducts over the Internet that claim to diagnose, prevent, treat, or cure theH1N1 influenza virus. The warning comes after the FDA recently purchasedand analyzed several products represented online as Tamiflu (oseltamivir) thatmay pose risks to patients. One of the orders, which arrived in an unmarkedenvelope with a postmark from India, consisted of unlabeled white tabletstaped between two pieces of paper. When analyzed by the FDA, the tabletswere found to contain talc and acetaminophen, but none of the activeingredient oseltamivir. The Web site disappeared shortly after the FDA placedthe order.Smoking Bans Reduce Heart Attack RiskWashington, DC — A report from the Institute of Medicine says thatsmoking bans are effective at reducing the risk of heart attacks and heartdisease associated with secondhand smoke. The report also provides evidencethat breathing secondhand smoke boosts the risk for heart problems innonsmokers, adding that there is evidence that relatively brief exposures couldlead to a heart attack. About 43% of nonsmoking children and 37% ofnonsmoking adults are exposed to secondhand smoke in the U.S., accordingto public health data.5U.S. <strong>Pharmacist</strong> • November 2009 • www.uspharmacist.com